Ignite Creation Date:
2024-05-06 @ 4:27 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT04999202
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2021-08-05
Brief Title:
A Study to Learn How Safe the Study Drug BAY 2416964 AhR Inhibitor in Combination With the Treatment Pembrolizumab is How This Combination Affects the Body the Maximum Amount That Can be Given How it Moves Into Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-14
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-05
First Submit QC Date:
August 5 2021
Study First Post Date:
2021-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL